CO2017009959A2 - Forma de dosificación dispersable - Google Patents

Forma de dosificación dispersable

Info

Publication number
CO2017009959A2
CO2017009959A2 CONC2017/0009959A CO2017009959A CO2017009959A2 CO 2017009959 A2 CO2017009959 A2 CO 2017009959A2 CO 2017009959 A CO2017009959 A CO 2017009959A CO 2017009959 A2 CO2017009959 A2 CO 2017009959A2
Authority
CO
Colombia
Prior art keywords
dosage form
dispersible dosage
dispersible
naturalized
synthetic
Prior art date
Application number
CONC2017/0009959A
Other languages
English (en)
Inventor
Joachim Schoelkopf
Patrick A C Gane
Tanja Stirnimann
Jörg Huwyler
Daniel E Gerard
Maxim Puchkov
Leonie Wagner-Hattler
Quijano Carolina Diaz
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of CO2017009959A2 publication Critical patent/CO2017009959A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F11/00—Compounds of calcium, strontium, or barium
    • C01F11/18—Carbonates
    • C01F11/185—After-treatment, e.g. grinding, purification, conversion of crystal morphology
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/10—Solid density
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/12—Surface area
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/14—Pore volume

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Geology (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seasonings (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención proporciona un método para mejorar la capacidad de flujo y la densidad de un material a granel sin compactar, de un material que comprende carbonato de calcio natural y/o sintético, funcionalizado, al uso de tal material mejorado en gránulos listo para su uso y a las formas de dosificación dispersables producidas a partir de los mismos.
CONC2017/0009959A 2015-03-20 2017-09-29 Forma de dosificación dispersable CO2017009959A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15160194.5A EP3069713A1 (en) 2015-03-20 2015-03-20 Dispersible dosage form
US201562203948P 2015-08-12 2015-08-12
PCT/EP2016/055590 WO2016150773A1 (en) 2015-03-20 2016-03-15 Dispersible dosage form

Publications (1)

Publication Number Publication Date
CO2017009959A2 true CO2017009959A2 (es) 2018-01-05

Family

ID=52686285

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2017/0009959A CO2017009959A2 (es) 2015-03-20 2017-09-29 Forma de dosificación dispersable

Country Status (16)

Country Link
US (1) US10617648B2 (es)
EP (2) EP3069713A1 (es)
JP (1) JP2018510162A (es)
KR (1) KR102119074B1 (es)
CN (1) CN107405308A (es)
AU (1) AU2016236390A1 (es)
BR (1) BR112017019927A2 (es)
CA (1) CA2978032C (es)
CO (1) CO2017009959A2 (es)
CR (1) CR20170427A (es)
MX (1) MX2017011774A (es)
PH (1) PH12017501546A1 (es)
RU (1) RU2733757C2 (es)
SG (1) SG11201707719WA (es)
TW (1) TW201641120A (es)
WO (1) WO2016150773A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3260115A1 (en) * 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3260114A1 (en) * 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3311665A1 (en) * 2016-10-21 2018-04-25 Omya International AG Use of surface-reacted calcium carbonate for preparing supersaturated aqueous systems
CN107255602B (zh) * 2017-06-06 2020-05-05 武汉烽火锐拓科技有限公司 在线测量疏松体密度的方法及装置
US20200131052A1 (en) * 2017-06-29 2020-04-30 Solenis Technologies Cayman, L.P. Water stable granules and tablets
JP6959669B2 (ja) * 2017-07-27 2021-11-02 白石工業株式会社 炭酸カルシウム、食品添加用炭酸カルシウム製剤及び食品
JP6719779B2 (ja) * 2017-07-27 2020-07-08 白石工業株式会社 炭酸カルシウムを含む食品
TW202200206A (zh) * 2020-04-28 2022-01-01 瑞士商歐米亞國際公司 包含表面反應碳酸鈣作為賦形劑之顆粒

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5512411B2 (es) 1974-03-12 1980-04-02
US4451260A (en) 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
US4985459A (en) 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
JPS6143108A (ja) 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
DK162986A (da) 1985-04-12 1986-10-13 Forest Laboratories Terapeutisk middel i enhedsdosisform
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
GB8809421D0 (en) 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
WO1995005809A1 (fr) 1993-08-20 1995-03-02 Nippon Shinyaku Co., Ltd. Preparation restant dans l'estomac, forme moulee gonflee, et procede de preparation
US5939091A (en) * 1997-05-20 1999-08-17 Warner Lambert Company Method for making fast-melt tablets
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
US6582738B2 (en) 1999-09-13 2003-06-24 Deseret Laboratories, Inc. Process for preparing chewing gum containing a nutritional supplement
NZ524572A (en) 2000-09-06 2004-08-27 Tanabe Seiyaku Co Oral compositions comprising phosphodiesterase inhibitors ( PDE inhibitor )and an acidic substance such as fumaric acid with improved drug efficacy due to decrease solubility in neutral and alkaline regions
US20030157213A1 (en) 2002-02-19 2003-08-21 Jeffrey Jenkins Nutrient chewing gum
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2881957B1 (fr) 2005-02-16 2008-08-08 Solvay Comprimes comprenant une substance biologiquement active et un excipient
FI20061146A0 (fi) * 2006-11-10 2006-12-21 Iprbox Oy Rakeita, tabletteja ja rakeistusmenetelmä
ATE480597T1 (de) 2007-12-12 2010-09-15 Omya Development Ag Verfahren zur herstellung von oberflächenreaktives fällungskalziumkarbonat
EP2168572A1 (en) 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
DK2264108T3 (da) 2009-06-15 2012-05-29 Omya Development Ag Fremgangsmåde til fremstilling af et calciumcarbonat, der har reageret på overfladen, under anvendelse af en svag syre
EP2264109B1 (en) 2009-06-15 2012-01-25 Omya Development AG Process for preparing surface-reacted calcium carbonate and its use
WO2011087629A2 (en) * 2009-12-22 2011-07-21 Fmc Corporation Microcrystalline cellulose and calcium carbonate compositions useful as recompactible pharmaceutical excipients
ES2550854T3 (es) 2012-06-28 2015-11-12 Omya International Ag Suspensión acuosa con alto contenido en sólidos de pigmentos y/o material de relleno y/o minerales en un entorno de pH acídico
ES2628371T3 (es) 2012-10-12 2017-08-02 Omya International Ag Formulación de forma farmacéutica sólida de disgregación rápida que comprende carbonato de calcio funcionalizado y método para su fabricación
RS54024B1 (en) 2012-10-12 2015-10-30 Omya International Ag GASTRORETENCY FORMULATION OF MEDICINES AND SYSTEMS FOR DELIVERY AND METHODS OF THEIR PREPARATION USING FUNCTIONALIZED CALCIUM CARBONATE
PL2997833T3 (pl) * 2014-09-22 2018-07-31 Omya International Ag Przereagowany powierzchniowo węglan wapnia stosowany jako środek przeciwzbrylający
EP3034070A1 (en) 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system

Also Published As

Publication number Publication date
BR112017019927A2 (pt) 2018-06-12
JP2018510162A (ja) 2018-04-12
TW201641120A (zh) 2016-12-01
CA2978032C (en) 2020-09-01
KR102119074B1 (ko) 2020-06-05
CR20170427A (es) 2018-04-02
SG11201707719WA (en) 2017-10-30
CN107405308A (zh) 2017-11-28
EP3069713A1 (en) 2016-09-21
US10617648B2 (en) 2020-04-14
PH12017501546A1 (en) 2018-02-05
MX2017011774A (es) 2017-12-04
CA2978032A1 (en) 2016-09-29
EP3270899A1 (en) 2018-01-24
WO2016150773A1 (en) 2016-09-29
KR20170129232A (ko) 2017-11-24
RU2017134394A (ru) 2019-04-03
US20180078506A1 (en) 2018-03-22
AU2016236390A1 (en) 2017-11-09
RU2733757C2 (ru) 2020-10-06
RU2017134394A3 (es) 2019-04-03

Similar Documents

Publication Publication Date Title
CO2017009959A2 (es) Forma de dosificación dispersable
MX2020009649A (es) Anticuerpos monoclonales contra bcma.
CL2017000545A1 (es) Anticuerpos anti-her2 e inmunoconjugados
SG10201909028UA (en) Aldehyde compounds for treating pulmonary fibrosis, hypoxia, and connective tissue and autoimmune disease
CR20170095A (es) Anticuerpos anti-cll-1 e inmunoconjugados referencias recíprocas con solicitudes relacionadas
AR097481A1 (es) Cocristales energéticos para el tratamiento de una formación subterránea
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
MX2015008820A (es) Vendaje principal permeable al fluido, que tiene un revestimiento de silicona.
UY33917A (es) ?composiciones para recubrimiento que comprenden submicropartículas que comprenden carbonato de calcio, proceso para prepararlas, y uso de las submicropartículas?.
CL2017000750A1 (es) Pienso de alta resistencia a la abrasión y de buena estabilidad en agua, que contiene pufa
EA201592239A1 (ru) Многокомпонентная система для изготовления раствора гидрокарбоната кальция, подходящая для реминерализации обессоленной воды и природной мягкой воды
PE20161498A1 (es) Composicion reactiva basada en bicarbonato de sodio y procedimiento para su produccion
AR097210A1 (es) Composición para la aglomeración de finos
CL2016000730A1 (es) Material micronizado que contiene carbonato alcalinotérreo para regular el ph de un suelo, método para regular el ph del suelo y uso de un material que contiene carbonato alcalinotérreo.
CL2016002065A1 (es) Proceso para la preparacion de un producto de relleno mineral.
CL2016002095A1 (es) Proceso para la preparación de un producto rellenador mineral
AR105919A1 (es) Particulados de tratamiento sin portadores para su uso en formaciones subterráneas
CL2020001172A1 (es) Proceso para la preparación de particulas de isoxazolina de gran tamaño.
EA201400937A1 (ru) Способ получения 2-(2,3-диметилфенил)-1-пропаналя
CL2017000613A1 (es) Proceso en seco para preparar un material que contiene carbonato de metal alcalinotérreo modificado de superficie
PL3745065T3 (pl) Reaktor do wytwarzania pary wodnej i suchej masy
CL2017001258A1 (es) Generación de inmunidad
CL2017000948A1 (es) Textile compuesto que consiste en fibras naturales y/o sintéticas y/o artificiales y partículas lignocelulósicas
CL2012002063A1 (es) Proceso para hacer biodegradable un material polimerico sintetico, que comprende la adicion al material sintetico de una o mas levaduras; equipo para la implementacion de dicho proceso; y uso de levaduras.
WO2015106973A3 (en) Anti-mif immunohistochemistry